News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
206 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (24953)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
3 (206)
4 (216)
5 (185)
6 (236)
7 (230)
10 (256)
11 (243)
12 (223)
13 (204)
14 (179)
15 (3)
16 (19)
17 (202)
18 (164)
19 (147)
20 (155)
21 (130)
22 (1)
24 (149)
25 (152)
26 (100)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
15
16
17
18
19
20
21
22
24
25
26
Drug Development
Results from Metabasis Therapeutics, Inc.’s Phase 2a Clinical Trial for MB07803 Show Statistically Significant Reductions in FPG, as Well as Safety and Tolerability
November 3, 2008
·
1 min read
Drug Development
Halozyme Therapeutics, Inc. Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
November 3, 2008
·
5 min read
Drug Development
Cell Therapeutics, Inc. Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
November 3, 2008
·
5 min read
Business
Omrix Biopharmaceuticals, Inc. Reschedules its Third Quarter 2008 Financial Results and Conference Call to an Earlier Time on November 6, 2008
November 3, 2008
·
1 min read
Drug Development
AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
November 3, 2008
·
6 min read
Drug Development
Anadys Pharmaceuticals, Inc. Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
November 3, 2008
·
8 min read
Genetown
Synta Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference
November 3, 2008
·
1 min read
Drug Development
Derma Sciences, Inc. Enrolls First Patient in DSC127 Phase II Study
November 3, 2008
·
7 min read
Biotech Bay
VIVUS, Inc. Announces Upcoming Webcasts and Conference Participation
November 3, 2008
·
1 min read
Business
Elite Pharmaceuticals, Inc. Elects Wall Street Veteran Jerry Treppel to the Board of Directors
November 3, 2008
·
1 min read
Previous
10 of 21
Next
